{"schema_version":"secwatch.filing_event.v1","accession":"0001040130-24-000020","form_type":"8-K","ticker":"PETS","cik":"0001040130","company_name":"PETMED EXPRESS INC","filed_at":"2024-04-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.986715+00:00","generated_at":"2026-06-03T22:43:46.929726+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"PetMed Express Q3 net loss $2.0M; completes sales tax restatement","bullets":["Revenue $65.3M, up 11% YoY, driven by PetCareRx acquisition; legacy sales declined.","Net loss $(0.10)/diluted share vs $(0.01) loss last year; Adjusted EBITDA $924K vs $2.7M.","Cash $49.4M, no debt; AutoShip & Save and PetPlus made up 52% of revenue (vs 42% a year ago).","Restatement completed; sales tax liability now $24.2M from prior $7.8M as of Mar 2023.","Company now current on all SEC filings; restatement had no impact on FY2024 revenue or cash."],"urls":{"canonical":"https://secwatch.observer/filing/0001040130-24-000020","json":"https://secwatch.observer/filing/0001040130-24-000020.json","markdown":"https://secwatch.observer/filing/0001040130-24-000020.md","text":"https://secwatch.observer/filing/0001040130-24-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1040130/000104013024000020/0001040130-24-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1040130/000104013024000020/pets-20240415.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T22:43:46.929726+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b245d511138c728841bf8137b6a6ffdbe249aa85","claim":"PETMED EXPRESS INC reported fiscal third quarter 2024 results: revenue Net sales for the quarter ended December 31, 2023, were $65.3 million, net income Net loss for the quarter ended December 31, 2023 was $2.0 million, EPS $(0.10) per diluted share.","evidence_excerpt":"Net sales for the quarter ended December 31, 2023, were $65.3 million, compared to $58.9 million for the third quarter in the prior year, an increase of 11% year over year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1040130/000104013024000020/0001040130-24-000020-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal third quarter 2024"},{"label":"Revenue","value":"Net sales for the quarter ended December 31, 2023, were $65.3 million"},{"label":"Net income","value":"Net loss for the quarter ended December 31, 2023 was $2.0 million"},{"label":"EPS","value":"$(0.10) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}